top of page
INSIGHTS
Search
Ensuring Access to Life-Saving Medicines: The Case for Compulsory Licensing in Rare Diseases
Rare diseases pose some of the gravest challenges in healthcare. Though uncommon individually, they collectively affect millions of people worldwide. Often these diseases require specialized, lifelong treatments that come with exorbitant price tags. In India, patients suffering from conditions such as spinal muscular atrophy (SMA), haemophilia, thalassemia, and others face tremendous hurdles obtaining affordable medicines. This has placed compulsory licensing, a legal provisi
5 days ago5 min read
Two-Days International Symposium on Strategies for Managing Pharmaceutical, Biotechnology & Chemical Patent Portfolios
We are happy to inform you all that IIPRD and Khurana & Khurana, in association with Cantor Colburn (US) and Fukami Patent Office (Japan)...
Dec 13, 20131 min read
Inventors, All Technologies Aren’t Worth Billions
Working in the IP/Technology Commercialization and Out-Licensing domain makes you assess and evaluate commercial viability of numerous IP...
Jul 31, 20118 min read
Anti Cancer drug: Making it Patient-driven, not Disease-driven
Introduction: French compatriots Ipsen and bioMérieux, have been few most potential companies, since 2007 in the development of...
Apr 11, 20114 min read
bottom of page